MyFinsight
Home
Blog
About
Contact
Cash and cash
equivalents
$30,789K
Marketable securities
$14,614K
Prepaid expenses and
other current assets
$1,540K
Total current assets
$46,943K
Right-of-use asset -
operating lease
$801K
Property and equipment,
net
$427K
Other assets
$393K
Total assets
$48,564K
Total liabilities and
stockholders equity
$48,564K
Total stockholders
equity
$35,520K
Total liabilities
$13,044K
Accumulated deficit
-$477,317K
Treasury stock, at cost,
4,522 shares of common...
$3,968K
Accumulated other
comprehensive gain (loss)
-$2K
Additional paid-in capital
$516,767K
Total current
liabilities
$12,795K
Operating lease
liabilities - non-current...
$249K
Common stock, 0.001 par
value 325,000,000...
$40K
Accrued expenses
$8,755K
Deferred revenue -
current portion
$1,710K
Accounts payable
$1,535K
Less operating lease
liabilities - current...
$699K
Notes payable
$96K
Back
Back
Balance Sheet
Vistagen Therapeutics, Inc. (VTGN)
Vistagen Therapeutics, Inc. (VTGN)
source: myfinsight.com